Drugs A-Z Is my price fair? Price changes Drug shortages Recalls Medicare prices Upcoming generics What people paid Guides Share what you paid
Theme

Generic drug

Fosaprepitant price, strengths & recalls

Fosaprepitant has no weekly pharmacy acquisition cost. 17 manufacturers make it. It is in shortage (being discontinued). It has 3 recalls on record, none ongoing. Its official label last changed on June 2, 2023.

Being discontinuedGeneric
No weekly pricePharmacy acquisition costs aren't published for this drug - usually because it's given in clinics or hospitals.

Fosaprepitant price by strength

What pharmacies pay for each strength and form this week, for the usual package. Choose one for its fair price, 52-week chart and makers.

Strength and formPer unitPharmacies pay4 weeks52 weeks
150 mg injectionNot priced this week

Supply status: shortages & recalls

In shortage1 product is short or being discontinued
No ongoing recalls3 recalls on record, latest Jan 31, 2024

Shortages

  • Fosaprepitant Dimeglumine, Injection, 150 mg/5 mL (NDC 63323-972-10)Fresenius Kabi USA, LLC · Being discontinued Apr 8, 2026 · Updated Apr 8, 2026Discontinuation of the manufacture of the drug

In a shortage, ask your pharmacist whether another strength, form or maker is in stock, and how much notice they need. What to do in a drug shortage.

Recalls

A recall names specific lots. Check the lot number on your package against the recall before you worry - and don't stop a medicine without asking your pharmacist. What to do if your medication is recalled.

What did you pay for fosaprepitant? Help the next person.

Every price shared helps the next person know what's fair - and shows which pharmacies charge the least. Anonymous, 30 seconds.

How were you treated? optional

Free, anonymous, no sign-up. Please don't include personal or health details. Community rules.

Official label & what changed

Last changedJune 2, 2023
Version12 of 3
EffectiveJun 30, 2022
Read the label

These highlights do not include all the information needed to use FOSAPREPITANT FOR INJECTION safely and effectively. See full prescribing information for FOSAPREPITANT FOR INJECTION.FOSAPREPITANT for injection, for intravenous use Initial U.S. Approval: 2008

We check this label every day. When it changes, the sections that changed appear here, old text beside new.

We show the official text and what changed; we don't interpret it. Ask your pharmacist or prescriber what a change means for you.

Approval, patents & generics

Application
NDA210064 · Teva Pharms USA
First approved
September 5, 2019 (7 years ago)
Approved label
PDF, Sep 6, 2019
Generic makers
10 approved generic applications on the market

Fosaprepitant questions

Is fosaprepitant in shortage?

Yes. 1 product is listed as in shortage or being discontinued (being discontinued). See which ones.

Has fosaprepitant been recalled?

3 recalls on record, none ongoing. Recalls name specific lots - check yours.

When did the fosaprepitant label last change?

The official label was last updated on June 2, 2023 (version 12). See what changed.

Talk about fosaprepitant

Be kind and stay on topic. No personal health details, links or selling. This is not medical advice.

No comments yet. Questions, tips, what worked for you - start the conversation.

Help the next person

Know what your pharmacy pays.

Every price you share shows someone else what's fair - and which pharmacies charge the least. It takes 30 seconds and it's anonymous.